AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

When it comes to pre-revenue biotechs, it's often a struggle to build an investment thesis beyond "if the medicine works, the ...

The company’s shares closed yesterday at $50.28. Olson covers the Healthcare sector, focusing on stocks such as Jasper Therapeutics, Amgen, and Viking Therapeutics. According to TipRanks, Olson has an ...

Morgan Stanley analyst Michael Ulz has maintained their bullish stance on XLO stock, giving a Buy rating yesterday. Michael Ulz has given his ...

Following Trump's election victory, investors responded Wednesday by pouring a lot of money into exchange-traded funds. In this week's ETF Wrap, Christine Idzelis broke down the money flows and the ...

Detailed price information for Yum China Holdings Inc (YUMC-N) from The Globe and Mail including charting and trades.

The biggest risk is competition in the growing GLP-1 marketplace. The latest news is that Viking Therapeutics' VK2735 ...

The Philadelphia Phillies recently raised close to $500 million in capital from three new investors, according to two people ...

The former president will return to the White House in January 2025 following his win over Vice President Kamala Harris.

Anti-semitic violence in Amsterdam following a soccer match prompted Bill Ackman’s decision to move his publicly-traded ...

Mason Capital opposes Grifols sale to Brookfield Asset Management, raising concerns about the potential acquisition in the ...

Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...